Back
Serina Therapeutics, Inc. 10K Form
Sell
4
SER
Serina Therapeutics, Inc.
Last Price:
$2.63
Seasonality Move:
-2.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SER News And Ratings
See the #1 stock for the next 7 days that we like better than SER
SER Financial Statistics
Sales & Book Value
| Annual Sales: | $56K |
|---|---|
| Cash Flow: | $-3.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.30 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.45010 |
|---|---|
| Net Income (TTM): | $-14.5M |
| Gross Margin: | $-138K |
| Return on Equity: | 0% |
| Return on Assets: | -156.79% |
Serina Therapeutics, Inc. Earnings Forecast
Key Serina Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 9 years for SER is -246.43%.
-
The Selling, General & Administrative Expenses for SER have been equal to 17,185.71% of Gross Profit Margin.
-
The Research & Development expenses have been 13,357.14% of Revenue.
-
The Net Earning history of SER is -20,012.50% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 4 years.
Serina Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SER |
| Website: | serinatherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 1.82 |
|---|---|
| Current Ratio: | 1.31 |
| Quick Ratio: | 0.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SER Technical Analysis vs Fundamental Analysis
Sell
4
Serina Therapeutics, Inc. (SER)
is a Sell
Is Serina Therapeutics, Inc. a Buy or a Sell?
-
Serina Therapeutics, Inc. stock is rated a SellThe current Serina Therapeutics, Inc. [SER] share price is $2.66. The Score for SER is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.